Laboratory Products
Safely Determine Vaccine Hypersensitivity
Dec 16 2021
Alpha Laboratories Ltd is pleased to introduce the new Polyethylene glycol allergens from Bühlmann to the UK. These are for use with the FlowCAST® basophil activation assay, providing a safer approach to determine those with a hypersensitivity reaction to PEG.
Allergy to Polyethylene glycol (PEG) is rare but can be severe. It is suspected to be the primary cause of allergic reactions in those individuals who have reacted adversely to COVID-19 vaccines. PEG is used as a stabiliser of lipid nanoparticles in the formulation of mRNA-based vaccines, thus allergy to it is increasingly being recognised.
Basophil activation testing (BAT) has been validated to support and investigate Polyethylene glycol (PEG) hypersensitivity reactions. BAT is performed on whole blood samples and offers a much safer, non-invasive alternative to allergy testing, compared with traditional in-vivo allergy tests, such as a skin prick test
PEGs at different molecular weights may result in different reactivity of patient basophils, so Bühlmann has produced several PEG allergens to maximise the chance of detecting an allergic response in a patient:
PEG 4000 - Linear PEG of molecular weight in the range of 3500-4500
PEG 2000 - Linear PEG of molecular weight in the range of 1900-2200
DMG PEG 2000 - Lipid component with a PEG 2000 chain
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark